Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding

Dis Markers. 2022 May 6:2022:2940578. doi: 10.1155/2022/2940578. eCollection 2022.

Abstract

Esophagogastric variceal bleeding (EGVB) is one of the main complications of portal hypertension, especially in patients with liver cirrhosis, and has a very high fatality rate. At present, the treatment methods for rupture and bleeding of gastroesophageal varices (GV) include drug therapy, compression hemostasis with three-lumen and two-balloon tube, endoscopic therapy, and interventional and surgical operations. Endoscopy and intervention or their combined application is the mainstream treatment modes in clinical practice, especially their combined application has been increasingly recognized by front-line clinicians. This article intends to discuss the application characteristics of the two treatment methods.

Publication types

  • Review

MeSH terms

  • Endoscopy / adverse effects
  • Esophageal and Gastric Varices* / complications
  • Esophageal and Gastric Varices* / therapy
  • Gastrointestinal Hemorrhage / complications
  • Gastrointestinal Hemorrhage / therapy
  • Humans
  • Hypertension, Portal* / complications
  • Hypertension, Portal* / therapy
  • Liver Cirrhosis / complications
  • Varicose Veins* / complications